Question 1

What is Silexion Therapeutics?

Accepted Answer

Silexion Therapeutics is a Entity.

Question 2

How often does Silexion Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Silexion Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 16, 2026.

Question 4

When was Silexion Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 16, 2026.

Question 5

What is Silexion Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Silexion Therapeutics in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Silexion Therapeutics?

Accepted Answer

Silexion Therapeutics to attend BIO Convention (Jun 16, 2026, 6 articles).

Question 8

How did the "Silexion Therapeutics to attend BIO Convention" event impact Silexion Therapeutics?

Accepted Answer

Silexion Therapeutics is attending the 2026 Cape Town International Convention Centre to host one-on-one meetings, which could lead to new partnerships or investments, positively impacting its market position and funding for its RNAi therapies.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.